<SEC-DOCUMENT>0001753926-24-000105-index.html : 20240116 <SEC-HEADER>0001753926-24-000105.hdr.sgml : 20240116 <ACCEPTANCE-DATETIME>20240116172802 ACCESSION NUMBER: 0001753926-24-000105 CONFORMED SUBMISSION TYPE: S-1/A PUBLIC DOCUMENT COUNT: 16 FILED AS OF DATE: 20240116 DATE AS OF CHANGE: 20240116 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Chromocell Therapeutics Corp CENTRAL INDEX KEY: 0001919246 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 863335449 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-1/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-269188 FILM NUMBER: 24536154 BUSINESS ADDRESS: STREET 1: 685 US HIGHWAY ONE CITY: NORTH BRUNSWICK STATE: NJ ZIP: 08902 BUSINESS PHONE: 9176446313 MAIL ADDRESS: STREET 1: 685 US HIGHWAY ONE CITY: NORTH BRUNSWICK STATE: NJ ZIP: 08902 </SEC-HEADER> <DOCUMENT> <TYPE>S-1/A <SEQUENCE>1 <FILENAME>g083881_s1a.htm <DESCRIPTION>S-1/A <TEXT> Document 1 - file: g083881_s1a.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-4.21 <SEQUENCE>2 <FILENAME>g083881_ex4-21.htm <DESCRIPTION>EXHIBIT 4.21 <TEXT> Document 2 - file: g083881_ex4-21.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-4.22 <SEQUENCE>3 <FILENAME>g083881_ex4-22.htm <DESCRIPTION>EXHIBIT 4.22 <TEXT> Document 3 - file: g083881_ex4-22.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-4.23 <SEQUENCE>4 <FILENAME>g083881_ex4-23.htm <DESCRIPTION>EXHIBIT 4.23 <TEXT> Document 4 - file: g083881_ex4-23.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-4.24 <SEQUENCE>5 <FILENAME>g083881_ex4-24.htm <DESCRIPTION>EXHIBIT 4.24 <TEXT> Document 5 - file: g083881_ex4-24.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-4.25 <SEQUENCE>6 <FILENAME>g083881_ex4-25.htm <DESCRIPTION>EXHIBIT 4.25 <TEXT> Document 6 - file: g083881_ex4-25.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-4.26 <SEQUENCE>7 <FILENAME>g083881_ex4-26.htm <DESCRIPTION>EXHIBIT 4.26 <TEXT> Document 7 - file: g083881_ex4-26.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-4.27 <SEQUENCE>8 <FILENAME>g083881_ex4-27.htm <DESCRIPTION>EXHIBIT 4.27 <TEXT> Document 8 - file: g083881_ex4-27.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-4.28 <SEQUENCE>9 <FILENAME>g083881_ex4-28.htm <DESCRIPTION>EXHIBIT 4.28 <TEXT> Document 9 - file: g083881_ex4-28.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-4.29 <SEQUENCE>10 <FILENAME>g083881_ex4-29.htm <DESCRIPTION>EXHIBIT 4.29 <TEXT> Document 10 - file: g083881_ex4-29.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.13 <SEQUENCE>11 <FILENAME>g083881_ex10-13.htm <DESCRIPTION>EXHIBIT 10.13 <TEXT> Document 11 - file: g083881_ex10-13.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.14 <SEQUENCE>12 <FILENAME>g083881_ex10-14.htm <DESCRIPTION>EXHIBIT 10.14 <TEXT> Document 12 - file: g083881_ex10-14.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.1 <SEQUENCE>13 <FILENAME>g083881_ex23-1.htm <DESCRIPTION>EXHIBIT 23.1 <TEXT> Document 13 - file: g083881_ex23-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-FILING FEES <SEQUENCE>14 <FILENAME>g083881_ex107.htm <DESCRIPTION>EXHIBIT 107 <TEXT> Document 14 - file: g083881_ex107.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>15 <FILENAME>img001_v1.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 15 - file: img001_v1.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>16 <FILENAME>img002_v1.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 16 - file: img002_v1.jpg
</DOCUMENT> </SEC-DOCUMENT>